Homologous prime-boost vaccination with OVA entrapped in self-adjuvanting archaeosomes induces high numbers of OVA-Specific CD8+ T cells that protect against subcutaneous B16-OVA melanoma

From National Research Council Canada

  1. (PDF, 895 KiB)
DOIResolve DOI: https://doi.org/10.3390/vaccines4040044
AuthorSearch for: 1; Search for: 1; Search for: 1
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
SubjectCD8 T cell response; archaeosome; prime-boost; B16; liposome; tumor vaccine; central memory; effector memory
Publication date
Peer reviewedYes
NPARC number23001165
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier47ccb66d-22f3-4b57-af88-ccd491e36d86
Record created2016-12-21
Record modified2020-06-02
Date modified: